Free-viewing gaze patterns reveal a mood-congruency bias in MDD during an affective fMRI/eye-tracking task

Author:

Sun Rui,Fietz Julia,Erhart Mira,Poehlchen Dorothee,Henco Lara,Brückl Tanja M.,Binder Elisabeth B.,Erhardt Angelika,Lucae Susanne,Grandi Norma C.,Namendorf Tamara,Elbau Immanuel,Leuchs Laura,Brem Anna Katharine,Schilbach Leonhard,Ilić-Ćoćić Sanja,Ziebula Julius,von Mücke-Heim Iven-Alex,Kim Yeho,Pape Julius,Czisch Michael,Saemann Philipp G.,Spoormaker Victor I.,

Abstract

AbstractMajor depressive disorder (MDD) has been related to abnormal amygdala activity during emotional face processing. However, a recent large-scale study (n = 28,638) found no such correlation, which is probably due to the low precision of fMRI measurements. To address this issue, we used simultaneous fMRI and eye-tracking measurements during a commonly employed emotional face recognition task. Eye-tracking provide high-precision data, which can be used to enrich and potentially stabilize fMRI readouts. With the behavioral response, we additionally divided the active task period into a task-related and a free-viewing phase to explore the gaze patterns of MDD patients and healthy controls (HC) and compare their respective neural correlates. Our analysis showed that a mood-congruency attentional bias could be detected in MDD compared to healthy controls during the free-viewing phase but without parallel amygdala disruption. Moreover, the neural correlates of gaze patterns reflected more prefrontal fMRI activity in the free-viewing than the task-related phase. Taken together, spontaneous emotional processing in free viewing might lead to a more pronounced mood-congruency bias in MDD, which indicates that combined fMRI with eye-tracking measurement could be beneficial for our understanding of the underlying psychopathology of MDD in different emotional processing phases.Trial Registration: The BeCOME study is registered on ClinicalTrials (gov: NCT03984084) by the Max Planck Institute of Psychiatry in Munich, Germany.

Funder

Max Planck Institute of Psychiatry

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,General Medicine

Reference60 articles.

1. Insel T, Cuthbert B, Garvey M et al (2010) Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry 167:748–751. https://doi.org/10.1176/appi.ajp.2010.09091379

2. Hariri AR, Tessitore A, Mattay VS et al (2002) The amygdala response to emotional stimuli: a comparison of faces and scenes. Neuroimage 17:317–323. https://doi.org/10.1006/nimg.2002.1179

3. Enhancing NeuroImaging Genetics through Meta-Analysis (ENIGMA) (1999) https://enigma.ini.usc.edu/ongoing/enigma-tbfmri/

4. Dunedin Multidisciplinary Health & Development Research Unit (The Dunedin Study) (1999) https://dunedinstudy.otago.ac.nz/

5. Human Connectome Project (2011) https://www.humanconnectome.org/

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Patient and Therapist Adoption Criteria for Mental Health Applications;2024 47th MIPRO ICT and Electronics Convention (MIPRO);2024-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3